SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

Effective clinical intervention strategies for COVID-19 are urgently needed. Although several clinical trials have evaluated the use of convalescent plasma containing virus-neutralizing antibodies, the levels of neutralizing antibodies are usually not assessed and the effectiveness has not been prov...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Haagmans, Bart L, Noack, Danny, Okba, Nisreen M A, Li, Wentao, Wang, Chunyan, Bestebroer, Theo, de Vries, Rory, Herfst, Sander, de Meulder, Dennis, Verveer, Elwin, van Run, Peter, Lamers, Mart M, Rijnders, Bart, Rokx, Casper, van Kuppeveld, Frank, Grosveld, Frank, Drabek, Dubravka, GeurtsvanKessel, Corine, Koopmans, Marion, Bosch, Berend Jan, Kuiken, Thijs, Rockx, Barry
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Major Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8243397/
https://ncbi.nlm.nih.gov/pubmed/34043806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiab289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars